Ayzeze: Le produit peut provoquer une réaction allergique. Avant utilisation, veuillez lire attentivement la notice et les informations indiquées sur l’emballage du produit. Pour plus d’informations, vous pouvez contacter directement le vendeur ou le fabricant.
-----
Ayzeze: Cet appareil ne remplace pas un avis médical, un diagnostic ou un traitement. En cas de doute, veuillez consulter un professionnel de santé qualifié avant toute utilisation. Le vendeur/distributeur décline toute responsabilité en cas de dommages résultant d'une mauvaise utilisation, d'une modification non autorisée ou d'une utilisation non conforme aux indications.
-----
Product Description (Overview)
MEDIHEAL Madecassoside Blemish Toner Derma Pads are intensive calming toner pads designed to help soothe irritated skin and improve blemish marks. Infused with Madecassoside for skin-soothing care and combined with a bonus set of PDRN pads, this derma pad set delivers targeted calming, hydration, and skin barrier support. Ideal for daily use on sensitive, acne-prone, or stressed skin.
Key Features
Madecassoside Calming Care – Helps soothe irritation and reduce blemish traces
Derma Toner Pads – Gently refine skin texture while delivering moisture
PDRN Pad Bonus – Additional skin-repair and vitality care
Multi-Use Pads – Use as toner wipe or calming spot mask
Suitable for Sensitive Skin – Dermatologically tested formula
How to Use
After cleansing, gently wipe the face with a toner pad, avoiding the eye area.
For intensive care, place pads on concerned areas for 3–5 minutes as a calming pack.
Pat remaining essence into the skin until fully absorbed.
Use daily, morning and evening.
Volume
Madecassoside Toner Derma Pads: 100 Pads
PDRN Pads (Bonus): 10 Pads
Total: 110 Pads
Ingredients:
Water (Aqua), Glycerin, Propanediol, Butylene Glycol, Madecassoside, Centella Asiatica Extract, Panthenol, Allantoin, Betaine, Sodium Hyaluronate, PDRN (Polydeoxyribonucleotide), Niacinamide, Adenosine, 1,2-Hexanediol, Ethylhexylglycerin, Carbomer, Arginine, Disodium EDTA.